emerging use of bpc 157 BPC-157: What It Is, What We Know, and Why Its for Arthritis Remains Unproven BPC-157 Oral vs Injection: Benefits,

Typical daily range: 200300 mcg once daily across a 48 week course

Journal of Endocrinology and Metabolism, 4(1-2), 87-95

A Multicenter, Randomized, Double Blind, Placebo Controlled Phase II Study of PL 14736 Enema in the Treatment of Mild-To-Moderate Ulcerative Colitis, Ulcerative Colitis Study Group

Compliance with Regulatory Standards: For BPC-157 to gain approval as a pharmaceutical drug, it must undergo the rigorous and costly drug development process mandated by regulatory bodies like the FDA and EMA

In the future, with increased scientific research investment, its application scenarios will be further expanded